T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PATI
1376
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
| $7.08M | ﹤0.01% |
294,359
+1,700
| +0.6% | +$38.9K |
|
1377
Rocket Pharmaceuticals
RCKT
$367M
| $7.05M | ﹤0.01% |
+187,491
| New | +$8.61M |
|
|
CSLT
1378
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $7.04M | ﹤0.01% |
1,677,273
-971,150
| -37% | -$6.13M |
|
|
ABAX
1379
DELISTED
Abaxis Inc
ABAX
| $7.04M | ﹤0.01% |
160,100
+2,000
| +1% | +$98.3K |
|
1380
Pitney Bowes
PBI
$2.28B
| $6.92M | ﹤0.01% |
348,581
| – | – |
|
1381
Charter Communications
CHTR
$18.7B
| $6.9M | ﹤0.01% |
39,220
-890
| -2% | -$162K |
|
|
HZN
1382
DELISTED
Horizon Global Corporation
HZN
| $6.88M | ﹤0.01% |
+780,616
| New | +$8.72M |
|
1383
Teradata
TDC
$2.57B
| $6.88M | ﹤0.01% |
237,561
-2,600
| -1% | -$83.3K |
|
|
LM
1384
DELISTED
Legg Mason, Inc.
LM
| $6.88M | ﹤0.01% |
165,330
-568,380
| -77% | -$26.3M |
|
|
AFFX
1385
DELISTED
Affymetrix Inc
AFFX
| $6.79M | ﹤0.01% |
795,700
+26,100
| +3% | +$261K |
|
|
CHK
1386
DELISTED
Chesapeake Energy Corporation
CHK
| $6.71M | ﹤0.01% |
4,578
-138
| -3% | -$234K |
|
|
PAY
1387
DELISTED
Verifone Systems Inc
PAY
| $6.66M | ﹤0.01% |
240,022
+3,800
| +2% | +$119K |
|
1388
CorVel
CRVL
$3.25B
| $6.61M | ﹤0.01% |
614,298
-19,500
| -3% | -$210K |
|
1389
O-I Glass
OI
$1.05B
| $6.6M | ﹤0.01% |
318,330
+29,600
| +10% | +$629K |
|
1390
Copart
CPRT
$27.2B
| $6.59M | ﹤0.01% |
1,601,600
+97,600
| +6% | +$431K |
|
|
ESL
1391
DELISTED
Esterline Technologies
ESL
| $6.56M | ﹤0.01% |
91,290
-3,100
| -3% | -$264K |
|
1392
Herc Holdings
HRI
$5.64B
| $6.46M | ﹤0.01% |
128,727
+14,194
| +12% | +$743K |
|
|
WFC.WS
1393
DELISTED
Wells Fargo & Company Ws
WFC.WS
| $6.43M | ﹤0.01% |
355,275
| – | – |
|
|
FLIR
1394
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $6.41M | ﹤0.01% |
228,910
+1,720
| +0.8% | +$50.8K |
|
|
AIG.WS
1395
DELISTED
American International Group, Inc.
AIG.WS
| $6.39M | ﹤0.01% |
281,700
| – | – |
|
1396
IQVIA
IQV
$39.8B
| $6.34M | ﹤0.01% |
91,200
+1,600
| +2% | +$120K |
|
|
PACW
1397
DELISTED
PacWest Bancorp
PACW
| $6.27M | ﹤0.01% |
146,485
+16,600
| +13% | +$744K |
|
1398
Nu Skin
NUS
$236M
| $6.26M | ﹤0.01% |
151,740
-4,862
| -3% | -$209K |
|
|
ESV
1399
DELISTED
Ensco Rowan plc
ESV
| $6.24M | ﹤0.01% |
110,863
-625
| -0.6% | -$43K |
|
1400
Deckers Outdoor
DECK
$12.7B
| $6.23M | ﹤0.01% |
644,160
-57,600
| -8% | -$643K |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.